2008 – Page 125 – The Stem Cell Foundation

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial

Post author:2by2host
Post published:April 17, 2008
Post category:Articles Cancer

Abstract Background: Early clinical trials have suggested that glutathione (GSH)offers protection from the toxic effects of cisplatin. Patients and methods: One hundred fifty-one patients with ovariancancer (stage I–IV) were evaluated in…

Glutathione Protects the Rat Liver Against Reperfusion Injury After Prolonged Warm Ischemia.

Post author:2by2host
Post published:April 17, 2008
Post category:Articles

Abstract: Objective: To evaluate the potential of postischemic intravenous infusion of the endogenous antioxidant glutathione (GSH) to protect the liver from reperfusion injury following prolonged warm ischemia. Background Data: The…

Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.

Post author:2by2host
Post published:April 17, 2008
Post category:Articles

OBJECTIVE: To assess the effects of glutathione on pain-free walking distance (PFWD) and hemodynamic parameters in patients with peripheral artery disease. PATIENTS AND METHODS: Forty patients with Fontaine stage II…

Intracoronary Infusion of Reduced Glutathione Improves Endothelial Vasomotor Response to Acetylcholine in Human Coronary Circulation

Post author:2by2host
Post published:April 17, 2008
Post category:Articles

Background—Oxygen free radicals have been shown to cause endothelial vasomotor dysfunction. This study examined the effect of reduced glutathione (GSH), an antioxidant, on human coronary circulation. Methods and Results—Responses of…